4//SEC Filing
PHOENIX BIOTECH SPONSOR, LLC 4
Accession 0000899243-21-039943
CIK 0001870404other
Filed
Oct 11, 8:00 PM ET
Accepted
Oct 12, 7:41 PM ET
Size
10.6 KB
Accession
0000899243-21-039943
Insider Transaction Report
Form 4
PHOENIX BIOTECH SPONSOR, LLC
10% Owner
Transactions
- Other
Class A common stock
2021-10-08$10.00/sh+36,733$367,330→ 699,996 total - Other
Class B Common Stock
2021-10-08−82,875→ 4,596,250 total→ Class A Common Stock (82,875 underlying) - Other
Warrants
2021-10-08+18,366→ 349,998 totalExercise: $11.50→ Class A Common Stock (18,366 underlying)
Footnotes (6)
- [F1]Acquisition by reporting person in connection with the partial exercise of the underwriters' over-allotment option.
- [F2]These shares underlie the same number of units of the issuer held by the reporting person.
- [F3]The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the issuer's initial business combination on a one-for-one basis, subject to certain adjustments described in the issuer's charter documents and have no expiration date.
- [F4]Forfeiture and cancellation of shares of Class B common stock for no consideration because the underwriters' over-allotment option was not exercised in full.
- [F5]The warrants will become exercisable at the later of 30 days after the consummation of the issuer's initial business combination or 12 months from the completion of the issuer's initial public offering.
- [F6]The warrants will expire five years after the consummation of the issuer's initial business combination or earlier upon redemption of all of the issuer's outstanding Class A common shares or the issuer's liquidation.
Documents
Issuer
PHOENIX BIOTECH ACQUISITION CORP.
CIK 0001870404
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001870407
Filing Metadata
- Form type
- 4
- Filed
- Oct 11, 8:00 PM ET
- Accepted
- Oct 12, 7:41 PM ET
- Size
- 10.6 KB